What is DiA Imaging Analysis?
Founded in 2009 and headquartered in the Southern District of Israel, DiA Imaging Analysis specializes in the development of AI-based software designed to automate the capture and analysis of ultrasound images. The company's core technology addresses the inherent variability in ultrasound interpretation by providing clinicians with real-time, objective feedback. By transforming how medical professionals interact with imaging hardware, DiA Imaging Analysis is effectively democratizing diagnostic accuracy, reducing the reliance on highly specialized expertise for routine scans, and improving patient outcomes through faster, more precise clinical decision-making.
How much funding has DiA Imaging Analysis raised?
DiA Imaging Analysis has raised a total of $19M across 2 funding rounds:
Unspecified
$5M
Series B
$14M
Unspecified (2018): $5M with participation from Connecticut Innovations, Israel Innovation Authority, and DEFTA Partners
Series B (2021): $14M led by Connecticut Innovations, Downing Ventures, Dr Shmuel Cabilly, DEFTA Partners, XTX Ventures, Icon Advisers, Philips, Mindset Ventures, CE Ventures, and Alchimia Ventures
Key Investors in DiA Imaging Analysis
DEFTA Partners
DEFTA Partners is a leader in global venture investment, focusing on innovative technologies in healthcare and information and communication technology with a presence in San Francisco, Tokyo, and Hong Kong.
Connecticut Innovations
Connecticut Innovations is the state's strategic venture capital arm, providing equity and debt financing to help innovative companies scale in sectors like AI and biosciences.
Philips
Philips is a diversified health and well-being company headquartered in the Netherlands, focused on improving lives through innovation in healthcare and clinical expertise.
What's next for DiA Imaging Analysis?
With the infusion of $14M, DiA Imaging Analysis is poised to enter a new phase of commercial expansion and product innovation. The strategic focus will likely center on deepening its integration with existing ultrasound hardware manufacturers and expanding its regulatory approvals in key global markets. By leveraging its robust capital position, the company is well-positioned to navigate the complexities of the healthcare technology sector, focusing on long-term value creation through continuous R&D and strategic partnerships. Future milestones will likely involve the deployment of its AI algorithms across a broader range of clinical applications, further cementing its status as a leader in the medical imaging software space.
See full DiA Imaging Analysis company page
